Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis

International Journal of Antimicrobial Agents

Volumn 23, Issue 3, 2004, Pages 306-309

  Lee, Hyuck ^a   Song, Jae Hoon ^b,d   Kim, Shin Woo ^c   Oh, Won Sup ^b   Jung, Sook In ^b   Kiem, Sungmin ^b   Peck, Kyong Ran ^b   Lee, Nam Yong ^b  

^a Dong A University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

^d Asian Pacific Research Foundation for Infectious Diseases   (South Korea)

Author keywords

Animal model; Ceftriaxone; Meningitis; Multi resistance; Rifampicin; Streptococcus pneumoniae; Vancomycin

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; RIFAMPICIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL MENINGITIS; BACTERIAL STRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SCREENING; NONHUMAN; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS PNEUMONIAE;

EID: 1442312050     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.07.015     Document Type: Conference Paper

References (10)

1. Appelbaum P.C. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin. Infect. Dis. 34:2002;1613-1620.
2. American Academy of Pediatrics. Therapy for children with invasive pneumococcal infections. Pediatrics 1997;99:289-99.
3. Kaplan S.L., Mason E.D. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin. Microbiol. Rev. 11:1998;628-644.
4. Friedland I.R., Paris M., Ehrett S., Hickey S., Olsen K., McCracken G.H. Evaluation of antimicrobial regimen for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37:1993;1630-1636.
5. John C.C. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 18:1994;188-193.
6. Lutsar I., Ahmed A., Friedland I., Trujillo M., Wubbel L., Olsen K.et al. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 41:1997;2414-2417.
7. Paris M.M., Hickey S.M., Uscher M.I., Shelton S., Olsen K.D., McCracken G.H. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 38:1994;1320-1324.
8. Klugman K.P., Friedland I.R., Bradley J.S. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39:1995;1988-1992.
9. Chowdhury M.H., Tunkel A.R. Antibacterial agents in infections of the central nervous system. Infect. Dis. Clin. North Am. 14:2000;391-408.
10. Doit C.P., Bonacorsi S.P., Fremaux A.J., Sissia G., Cohen R., Geslin P.L.et al. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis. Antimicrob. Agents Chemother. 38:1994;2655-2659.